Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function

Malignant melanoma is the deadliest form of skin cancer; the treatment of advanced and recurrent forms remains a challenge. It has recently been reported that growth hormone-releasing hormone (GHRH) receptor is involved in the pathogenesis of melanoma. Therefore, we investigated the effects of our n...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cell Cycle
Main Authors: Szalontay, Luca, Schally, Andrew V, Popovics, Petra, Vidaurre, Irving, Krishan, Awtar, Zarandi, Marta, Cai, Ren-Zhi, Klukovits, Anna, Block, Norman L, Rick, Ferenc G
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2014
Teme:
Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4615138/
https://ncbi.nlm.nih.gov/pubmed/25486366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/15384101.2015.945879
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki